pharma mystery
Mar. 25th, 2010 10:02 pmI don't understand the drug industry. Ok, ok, nobody does. Let me be more specific: I don't understand what's going on with one of my glaucoma drugs, Xalatan.
This drug has been on the market since 1996 without a generic option, meaning it costs more than $100 a month if you pay for it yourself (which of course most people don't, but delving into insurance-based pricing in this post would be scope creep). My co-pay is higher for a name-brand drug than for a generic, so I have personal interest in this going generic.
About a year ago word on the street was that the patent was due to expire last September, but something seems to have happened because it's now, according to the patent office, locked in until early 2011. According to my doctor, some insurance companies are applying pressure to ophthamologists, pushing them to use different drugs instead to treat this condition because of the expense. One way or another, it appears that Pfizer has about another year to collect the big bucks from customers before they have to accept that a 15-year monopoly is a pretty good run.
Given all that, I was surprised at this morning's checkup to receive not only a free sample (a month's supply) but also a card that I can use four times or up to $350, whichever comes first, getting my prescription filled. So my next four bottles of the stuff will be free. Before I use that up I'll have another checkup, at which I might score another freebie and perhaps another card. Even if the promotion is over by then, they'll have given up four months' worth of monopoly pricing on me in their final year of being guaranteed to collect it.
How is this in their interest? I'm happy to pocket the savings; I've been pouring money into keeping my glaucoma at bay for as long as I've been paying my own bills. (It was diagnosed when I was a child.) But I don't understand why I'm getting these savings at this time.
This drug has been on the market since 1996 without a generic option, meaning it costs more than $100 a month if you pay for it yourself (which of course most people don't, but delving into insurance-based pricing in this post would be scope creep). My co-pay is higher for a name-brand drug than for a generic, so I have personal interest in this going generic.
About a year ago word on the street was that the patent was due to expire last September, but something seems to have happened because it's now, according to the patent office, locked in until early 2011. According to my doctor, some insurance companies are applying pressure to ophthamologists, pushing them to use different drugs instead to treat this condition because of the expense. One way or another, it appears that Pfizer has about another year to collect the big bucks from customers before they have to accept that a 15-year monopoly is a pretty good run.
Given all that, I was surprised at this morning's checkup to receive not only a free sample (a month's supply) but also a card that I can use four times or up to $350, whichever comes first, getting my prescription filled. So my next four bottles of the stuff will be free. Before I use that up I'll have another checkup, at which I might score another freebie and perhaps another card. Even if the promotion is over by then, they'll have given up four months' worth of monopoly pricing on me in their final year of being guaranteed to collect it.
How is this in their interest? I'm happy to pocket the savings; I've been pouring money into keeping my glaucoma at bay for as long as I've been paying my own bills. (It was diagnosed when I was a child.) But I don't understand why I'm getting these savings at this time.
(no subject)
Date: 2010-03-26 02:36 am (UTC)(no subject)
Date: 2010-03-26 02:54 am (UTC)I have no brand loyalty for drugs (or much of anything else where I can't perceive a difference). If my doctor says there's equivalent, I will take the generic that costs me $10 a pop (and with the lower overall price) instead of the name brand that costs me $25 a pop. (My insurance company charges the higher co-pay for all name-brand drugs, not just the ones for which a generic is available.)
(no subject)
Date: 2010-03-26 12:32 pm (UTC)I'm pretty wary of new generics now.
(no subject)
Date: 2010-03-26 01:09 pm (UTC)(no subject)
Date: 2010-03-26 05:18 pm (UTC)And as someone else already said, not all generics are actually equivalent to their name-brand inspiration... We ran into that with one of my kids' meds and had a brief fight with the insurance co until the prescribing doc got on our side and signed on the "brand-name specified" line of the script each time.
(no subject)
Date: 2010-03-26 05:33 pm (UTC)(no subject)
Date: 2010-03-26 10:07 pm (UTC)(no subject)
Date: 2010-03-26 02:39 am (UTC)"This American Life" did a story about this tactic during one of their shows about the health care industry; I don't remember which show it was, but here's an NPR story on the same subject: http://www.npr.org/templates/story/story.php?storyId=113969968
(no subject)
Date: 2010-03-26 02:52 am (UTC)So it sounds like the best use of this card (taking the long-term into account) is for me to use it as if I didn't have insurance. I might only get three months free instead of four, but I won't be helping to raise my own insurance premiums later.
(no subject)
Date: 2010-03-26 03:58 am (UTC)They drive us nuts, frankly, mainly because folks treat them as point-of-sale coupons, and they're not. We fill the Rx, then the patient comes in to pick it up and hands the clerk the card at the counter. Now we have to cancel the transaction, reverse out the claim, input the card as a secondary insurance, bill the primary again, then process the coordination-of-benefits transaction. All while the patient is tapping their fingers on the counter. But, of course, I digress.
Mostly, they're for brand-only drugs in high teirs where there are generics in the same categoiry. I don't understand the economic mechanics, either. One of the most popular programs is for Lipitor, which has staved off a generic for *way* longer than anyone expected. You have to understand, as soon as a generic comes out, the brand market share is gone. Just...gone. Pffft. So it's in their interest to pay their lawyers whatever it takes. How they're managing to eat the coupon charges, though, that I don't quite get.
(no subject)
Date: 2010-03-26 01:12 pm (UTC)(no subject)
Date: 2010-03-26 12:02 pm (UTC)(no subject)
Date: 2010-03-26 01:15 pm (UTC)(no subject)
Date: 2010-03-26 01:55 pm (UTC)(no subject)
Date: 2010-03-26 03:04 pm (UTC)(no subject)
Date: 2010-03-26 10:09 pm (UTC)(no subject)
Date: 2010-03-27 01:35 am (UTC)But advocates of "medical marijuana" claims it only works for their purposes if smoked in natural leaf form. I'm skeptical, but...whatever. So the states
where it's legal permit -- in theory -- the dispensing of real weed. Who's gonna grow it, who's gonna sell it...that's another issue entirely. Don't look at me %^).